This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
S$0.01738
Share price
-33.50%
Change (1 day)
-98.95%
Change (1 year)
Categories
Earnings for Athersys (ATHX)
Earnings in 2023 (TTM): -S$56.26 Million
According to Athersys's latest financial reports the company's current earnings are S$0.08 Million. In 2022 the company made an earning of -S$99.16 Million, an increase over its 2021 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Athersys from 2007 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -S$56.26 Million | -43.26% |
| 2022 | -S$99.16 Million | -11.54% |
| 2021 | -S$0.12 Billion | 11.14% |
| 2020 | -S$0.11 Billion | 72.2% |
| 2019 | -S$58.57 Million | 77.29% |
| 2018 | -S$33.04 Million | -22.91% |
| 2017 | -S$42.86 Million | 111.89% |
| 2016 | -S$20.23 Million | -8.52% |
| 2015 | -S$22.11 Million | -40.81% |
| 2014 | -S$37.36 Million | 18.62% |
| 2013 | -S$31.49 Million | |
| 2011 | -S$17.75 Million | 19.71% |
| 2010 | -S$14.83 Million | -26.28% |
| 2009 | -S$20.11 Million | -18.21% |
| 2008 | -S$24.59 Million | -8.28% |
| 2007 | -S$26.81 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | S$8.56 B | -16,023.57% | 🇺🇸 USA |
 Pfizer PFE | S$13.31 B | -24,861.75% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | S$7.86 B | -14,725.74% | 🇺🇸 USA |
 Moderna
MRNA | -S$4.37 Billion | 8,010.24% | 🇺🇸 USA |
 Johnson & Johnson JNJ | S$35.28 B | -65,729.04% | 🇺🇸 USA |
 United States Lime & Minerals USLM | S$0.19 B | -461.74% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | -S$0.81 Billion | 1,401.18% | 🇺🇸 USA |
 Merck MRK | S$27.61 B | -51,462.48% | 🇺🇸 USA |
 Sanofi SNY | S$11.29 B | -21,097.75% | 🇫🇷 France |